Science and Research

D7700C00003_ CLEAR

A Phase IIb Randomized, Double-blind, Placebo-controlled,
Parallel, Multidose Study to Evaluate the Efficacy, Safety, and PK
of AZD0292 in Participants 12 years of Age and Older With
Bronchiectasis and Chronic Pseudomonas aeruginosa Colonization

Study details
Study-ID: 2025-523009-14
Study-ID: 2025-523009-14
DZL Disease Area: CFBE
DZL Disease Area: CFBE
Study Type: Interventional
Study Type: Interventional
DZL Role: DZL recruiting center
DZL Role: DZL recruiting center
Funding: Externally - industry
Funding: Externally - industry
DZL Participating Sites: BREATH
DZL Participating Sites: BREATH
Start Date: 11.12.2025
Completion Date: 01.01.2027
Status: Recruiting
Status: Recruiting
DZL recruiting center


chevron-down